CLOs on the Move

Marathon Pharmaceuticals is dedicated to improving the lives of patients with few or no treatment options by delivering new medicines for rare diseases and keeping small volume, hard-to-manufacture medications available for people who need them. There are more than 6,000 recognized rare diseases for which no treatment exists. Many pharmaceutical companies are unwilling or unable to invest in treatments for diseases that affect fewer than 200,000 patients. Marathon is different.Marathon was founded to tackle the toughest challenge in medicine: developing treatments for the most complex rare diseases. All corporate profits are reinvested to build our pipeline of promising rare disease treatments. As a ...

Marathon Pharmaceuticals is dedicated to improving the lives of patients with few or no treatment options by delivering new medicines for rare diseases and keeping small volume, hard-to-manufacture medications available for people who need them. There are more than 6,000 recognized rare diseases for which no treatment exists. Many pharmaceutical companies are unwilling or unable to invest in treatments for diseases that affect fewer than 200,000 patients. Marathon is different.Marathon was founded to tackle the toughest challenge in medicine: developing treatments for the most complex rare diseases. All corporate profits are reinvested to build our pipeline of promising rare disease treatments. As a privately held company, Marathon can devote its resources to developing new therapies that might not otherwise reach patients. Marathon’s branded prescription medicines are used to treat a variety of conditions. We work to ensure that these important medicines are available for those who need them by investing heavily in high quality manufacturing and a reliable supply chain.

More>>

<<Less